- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT02970422
Chronic Obstructive Pulmonary Disease Patient Preferences Survey
COPD Patient Preferences, Activities, and Participation Survey
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Effettivo)
Contatti e Sedi
Luoghi di studio
-
-
Quebec
-
Montreal, Quebec, Canada, H4A 3J1
- Montreal Chest Institute of the McGill University Health Center (MUHC)
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- Clinical diagnosis of COPD
- English or French speaking
- Patient at one of the three participating sites with medical chart
Exclusion Criteria:
- No diagnosis of COPD by a healthcare professional
- Unable to communicate in English or French
- Unable to provide informed consent
- No medical chart information at one of the three participating sites
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Coorti e interventi
Gruppo / Coorte |
Intervento / Trattamento |
---|---|
Quartile 1 [Mild]
|
Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.
|
Quartile 2 [Moderate]
|
Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.
|
Quartile 3 [Severe]
|
Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.
|
Quartile 4 [Very Severe]
|
Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Number of Participants Who Prioritized Healthcare Topics
Lasso di tempo: Baseline
|
Twenty-four healthcare topics were selected once again from a literature and expert panel review, as well as corroborated by individuals living with COPD in five focus groups.
Example healthcare topics include: relief of breathlessness; increase maximal amount of exercise individuals living with COPD can do inside and outside their homes; and prevent-lung flare-ups.
Participants were asked to indicate their preference of the topics by assigning a percentage of their time, in increments of 10%, to the various healthcare topics, for a total of 100% of their time.
For the 24 healthcare topics, individuals could select up to 10 topics (10% times 10 topics, for 100% of their time).
The top five topics are presented as the most important topics for the participants and are indicative of areas of focus for future healthcare and research.
The top five were presented in accordance to the request from the working group who developed the survey and reviewed the results.
|
Baseline
|
Number of Participants Who Prioritized Research Topics
Lasso di tempo: Baseline
|
Individuals were asked to indicate their research priorities from a list of research topics using a modified willingness-to-pay method (Kawata et al., 2014).
The willingness-to-pay method allows individuals to assign preference to various topics by assigning a percentage of funds to the topic.
A list of 22 research topics (e.g., to relieve breathlessness in individuals living with COPD, to increase access to lung transplantations) was created for this study through a literature review, expert consultation, and five focus groups with individuals living with COPD (n=23, 27% women).
Individuals were asked to assign a percentage of funds, in increments of 10% of funding, to the 22 COPD research topics.
Participants could assign anywhere between 10% of funding to 100% of funding to the topics.
The top five were presented in accordance to the request from the working group who developed the survey and reviewed the results.
|
Baseline
|
Number of Participants Who Were Not Satisfied With Their Participation in Daily and Social Activities
Lasso di tempo: Baseline
|
Participants will answer questions about their participation in 26 daily activities, as well as their desire to participate in each of the 26 daily activities. This is a measure of those who indicated they wanted to increase their participation. 10 of the 26 activities and their outcome measures are listed below. Activity 1: Walking from one place to another outside of your home on a flat surface. Activity 2: Moving from one place to another using motorized transportation. Activity 3: Climbing two or more flights of stairs. Activity 4: Walking up a hill. Activity 5: Participating in regular exercise. Activity 6: Walking from one place to another in your home. Activity 7: Carrying light objects on a flat surface. Activity 8: Carrying heavy objects on a flat surface. Activity 9: Carrying-out low intensity physical activities |
Baseline
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Forced Expiratory Volume in 1-sec (FEV1)
Lasso di tempo: Baseline
|
Individuals forced expiratory volume in 1-sec (FEV1) as assessed by spirometry
|
Baseline
|
FEV1/FVC
Lasso di tempo: Baseline
|
Individuals FEV1-to-forced vital capacity (FVC) ratio
|
Baseline
|
Modified Medical Research Council Questionnaire on Breathlessness
Lasso di tempo: Baseline
|
Self-reported intensity of activity related breathlessness as assessed by the modified Medical Research Council (mMRC) dyspnea scale (0-4).
This questionnaire was used to measure participants' breathlessness burden using a single item scale from 0 to 4, where a score of 0-1 indicated mild breathlessness and 2-4 indicated increased breathlessness.
|
Baseline
|
COPD Assessment Test
Lasso di tempo: Baseline
|
This questionnaire measure the impact COPD is having on well being and daily life.
The CAT is an eight-item semantic differential scale from 0 to 5, where 0 is no impact and 5 is extremely impactful.
Items include: I never cough| I cough all the time, I have no phlegm (mucus) in my chest at all | My chest is completely full of phlegm (mucus), My chest does not feel tight at all | My chest feels very tight, When I walk up a hill or one flight of stairs, I am not breathless | When I walk up a hill or one flight of stairs, I am very breathless, I am not limited doing any activities at home| I am very limited doing activities at home, I am confident leaving my home despite my lung condition| I am not at all confident leaving my home because of my lung condition, I sleep soundly | I don't sleep soundly because of my lung condition, I have lots of energy I have no energy at all.
Participants' scores were totaled and a score of ≥ 10 indicated higher than normal burden of disease.
|
Baseline
|
Godin Leisure Time Physical Activity Questionnaire
Lasso di tempo: Baseline
|
Self-reported physical activity levels measured in length of bouts over the previous 7 days to determine physical activity frequency.
|
Baseline
|
Satisfaction of Life Questionnaire
Lasso di tempo: Baseline
|
This 5 item questionnaire was used to measure participants' level of life satisfaction.
The higher the score, the higher the sense of life satisfaction.
A score from 5-9 indicated extremely dissatisfied, 10-14 is dissatisfied, 15-19 indicated slightly below average life satisfaction.
20-24 is the average score, 25-29 is a high score indicative of higher life satisfaction and a score between 30-35 is a very high score and represent very high life satisfaction.
|
Baseline
|
Number of Participants With Exacerbations Due to COPD in the Preceding 12 Months
Lasso di tempo: baseline
|
An exacerbation was defined as a change in medication due to a COPD exacerbation (i.e., the prescription of prednisone or a medical action plan) as indicated in the medical chart or hospital admission due to a COPD exacerbation.
|
baseline
|
Collaboratori e investigatori
Sponsor
Collaboratori
Investigatori
- Investigatore principale: Shane N Sweet, Ph.D., McGill University
Pubblicazioni e link utili
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 15-203-MUHC
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Patient Survey
-
Children's Mercy Hospital Kansas CityReclutamentoDiabete mellito di tipo 1Stati Uniti
-
University of Alabama at BirminghamCompletatoFibrosi cisticaStati Uniti
-
Optimum Patient CareRespiratory Effectiveness Group; Boehringer Ingelheim Pharmaceutical Company... e altri collaboratoriSconosciutoBroncopneumopatia Cronica Ostruttiva (13645005)Stati Uniti
-
Tammy MooreAttivo, non reclutante
-
Ad scientiamCompletato
-
Assistance Publique - Hôpitaux de ParisSconosciuto
-
GE HealthcareTerminatoPressione sanguignaStati Uniti, India
-
Brigham and Women's HospitalNational Institutes of Health (NIH); National Library of Medicine (NLM)SconosciutoCancro | Perdita dell'udito | Cardiomiopatia ipertroficaStati Uniti, Canada
-
NYU Langone HealthAgency for Healthcare Research and Quality (AHRQ)Non ancora reclutamentoDiabete di tipo 2Stati Uniti
-
National Institute of Medical Sciences and Nutrition...ReclutamentoQualità della vita | Malattie reumatiche | Dignità | Angoscia, EmotivoMessico